Commerzbank Aktiengesellschaft FI Takes Position in Axon Enterprise, Inc. (NASDAQ:AXON)

Commerzbank Aktiengesellschaft FI purchased a new stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON) in the fourth quarter, according to its most recent 13F filing with the SEC. The fund purchased 407 shares of the biotechnology company’s stock, valued at approximately $246,000.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in AXON. Prestige Wealth Management Group LLC grew its position in Axon Enterprise by 115.8% in the third quarter. Prestige Wealth Management Group LLC now owns 82 shares of the biotechnology company’s stock worth $33,000 after acquiring an additional 44 shares in the last quarter. New Wave Wealth Advisors LLC purchased a new position in Axon Enterprise in the fourth quarter worth $40,000. Brooklyn Investment Group purchased a new position in Axon Enterprise in the third quarter worth $41,000. Y.D. More Investments Ltd purchased a new position in Axon Enterprise in the fourth quarter worth $45,000. Finally, Planning Capital Management Corp grew its position in Axon Enterprise by 83.3% in the third quarter. Planning Capital Management Corp now owns 121 shares of the biotechnology company’s stock worth $48,000 after acquiring an additional 55 shares in the last quarter. 79.08% of the stock is currently owned by hedge funds and other institutional investors.

Axon Enterprise Stock Performance

Shares of NASDAQ:AXON opened at $534.96 on Thursday. The company has a market cap of $40.79 billion, a price-to-earnings ratio of 138.23, a price-to-earnings-growth ratio of 5.17 and a beta of 1.12. The company has a 50-day moving average price of $605.52 and a 200-day moving average price of $527.52. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32. Axon Enterprise, Inc. has a 12 month low of $273.52 and a 12 month high of $715.99.

Insider Activity

In other Axon Enterprise news, President Joshua Isner sold 1,291 shares of the firm’s stock in a transaction dated Tuesday, December 17th. The shares were sold at an average price of $642.43, for a total value of $829,377.13. Following the completion of the sale, the president now directly owns 181,892 shares in the company, valued at $116,852,877.56. This trade represents a 0.70 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. Also, Director Michael Garnreiter sold 1,000 shares of the firm’s stock in a transaction dated Monday, December 16th. The stock was sold at an average price of $639.69, for a total transaction of $639,690.00. Following the completion of the sale, the director now owns 24,259 shares of the company’s stock, valued at $15,518,239.71. This trade represents a 3.96 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 5,146 shares of company stock valued at $3,262,847. Insiders own 6.10% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on AXON. The Goldman Sachs Group upped their target price on shares of Axon Enterprise from $500.00 to $700.00 and gave the stock a “buy” rating in a research report on Monday, January 27th. Craig Hallum downgraded shares of Axon Enterprise from a “buy” rating to a “hold” rating and set a $625.00 price target for the company. in a research note on Thursday, February 20th. Barclays set a $726.00 price target on shares of Axon Enterprise and gave the stock an “overweight” rating in a research note on Thursday, February 27th. Morgan Stanley raised shares of Axon Enterprise from an “equal weight” rating to an “overweight” rating and boosted their price target for the stock from $500.00 to $700.00 in a research note on Tuesday, December 3rd. Finally, Northland Securities boosted their price target on shares of Axon Enterprise from $365.00 to $550.00 and gave the stock an “outperform” rating in a research note on Monday, November 11th. Three research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $587.38.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.